DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $291,000 | -64.6% | 5,104 | -47.9% | 0.00% | -100.0% |
| Q4 2020 | $821,000 | +133.9% | 9,800 | 0.0% | 0.00% | – |
| Q3 2020 | $351,000 | +48.1% | 9,800 | 0.0% | 0.00% | – |
| Q2 2020 | $237,000 | +37.8% | 9,800 | 0.0% | 0.00% | – |
| Q1 2020 | $172,000 | 0.0% | 9,800 | -1.0% | 0.00% | – |
| Q4 2019 | $172,000 | +13.2% | 9,900 | 0.0% | 0.00% | – |
| Q3 2019 | $152,000 | -22.1% | 9,900 | +5.3% | 0.00% | – |
| Q2 2019 | $195,000 | -10.6% | 9,400 | 0.0% | 0.00% | – |
| Q1 2019 | $218,000 | +12.4% | 9,400 | 0.0% | 0.00% | – |
| Q4 2018 | $194,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |